The management of Molecule 77 has announced that it is seeking an acquisition or partnership in its IP. Additional funding for clinical studies and patent in process may increase value and required investment up to double the initial round.
For more information, please contact the company.
Molecule 77 announces business opportunity
Exciting Product Development
We have isolated a cannabinoid-based healing compound that can
- accelerate healing of fractures
- restore lost productivity due to incapacitation
- promote mental health accompanying traumatic injuries, including PTSD, anxiety and post-traumatic depression
Estimated potential market size: $200 billion annually worldwide.